Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2015

01.06.2015 | Original Article

Effects of cell-type-specific expression of a pan-caspase inhibitor on renal fibrogenesis

verfasst von: Tsutomu Inoue, Takeru Kusano, Kouji Tomori, Hidetomo Nakamoto, Hiromichi Suzuki, Hirokazu Okada

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The caspase family of enzymes is grouped into two major sub-families, namely apoptotic and inflammatory caspases, which play central roles in the induction of apoptosis, regulation of inflammation and immunity, and cellular differentiation.

Methods

The role of caspase activation in tubular epithelium and interstitial cells of 3 lines of transgenic mice with obstructed nephropathy was examined: p35 mice bearing the pan-caspase inhibitor protein expressed by the p35 gene separated from the universal CAG promoter by a floxed STOP sequence were crossed with γGT.Cre and FSP1.Cre mice that express Cre recombinase in the cortical tubular epithelium and FSP1+ interstitial cells, respectively. The γGT.Cre;p35, FSP1.Cre;p35 and p35 control mice were then challenged with unilateral ureter obstruction (UUO).

Results

Proinflammatory parameters such as protein levels of active IL-1β subunit and mRNA levels of TNF-α and NOD-like receptor pyrin domain containing-3, and profibrogenic parameters such as interstitial matrix deposition and mRNA levels of fibronectin EIIIA isoform and α1 chain of procollagen type I in the kidneys were significantly increased at 7 days in the FSP1.Cre;p35- and p35-UUO mice, but not in the γGT.Cre;p35-UUO mice. These changes paralleled the numbers of apoptotic nuclei in tubules, but not in interstitial cells, and the protein levels of active caspase-3 subunit in the kidneys of FSP1.Cre;p35-, p35- and γGT.Cre;p35-UUO mice.

Conclusion

This study provides evidence of the critical role of caspase activation in the tubular epithelium, but not in FSP1+ interstitial cells, in apoptosis and inflammasome induction, leading to proinflammatory and profibrogenic processes in fibrous kidneys with UUO.
Literatur
2.
Zurück zum Zitat Sung JH, Zhao H, Roy M, Sapolsky RM, Steinberg GK. Viral caspase inhibitor p35, but not crmA, is neuroprotective in the ischemic penumbra following experimental stroke. Neuroscience. 2007;149:804–12.PubMedCentralPubMedCrossRef Sung JH, Zhao H, Roy M, Sapolsky RM, Steinberg GK. Viral caspase inhibitor p35, but not crmA, is neuroprotective in the ischemic penumbra following experimental stroke. Neuroscience. 2007;149:804–12.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Chandrashenkhar Y, Anway R, Shuros A, Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol. 2004;43:295–301.CrossRef Chandrashenkhar Y, Anway R, Shuros A, Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol. 2004;43:295–301.CrossRef
4.
Zurück zum Zitat Daemen MARC, van’t Veer C, Denecker G, Heemskerk VH, Wolfs TGAM, Clauss M, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541–9.PubMedCentralPubMedCrossRef Daemen MARC, van’t Veer C, Denecker G, Heemskerk VH, Wolfs TGAM, Clauss M, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541–9.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008;19:1634–42.PubMedCrossRef Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008;19:1634–42.PubMedCrossRef
6.
Zurück zum Zitat Bryant C, Fitzgerald KA. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 2009;19:455–64.PubMedCrossRef Bryant C, Fitzgerald KA. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 2009;19:455–64.PubMedCrossRef
7.
Zurück zum Zitat Docherty NG, O’Sullivan OE, Healy DA, Fitzpatrick JM, Watson RWG. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol. 2006;290:F4–13.PubMedCrossRef Docherty NG, O’Sullivan OE, Healy DA, Fitzpatrick JM, Watson RWG. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol. 2006;290:F4–13.PubMedCrossRef
8.
Zurück zum Zitat Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, et al. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. PNAS. 2005;102:6954–9.PubMedCentralPubMedCrossRef Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, et al. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. PNAS. 2005;102:6954–9.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Seery JP, Cattell V, Watt FM. Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-ananyl-aspartyl-(beta-o-methyl)-fluoromethylketone. J Immunol. 2001;167:2452–5.PubMedCrossRef Seery JP, Cattell V, Watt FM. Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-ananyl-aspartyl-(beta-o-methyl)-fluoromethylketone. J Immunol. 2001;167:2452–5.PubMedCrossRef
10.
Zurück zum Zitat Yang B, Johnson TS, Haylor JL, Wagner B, Watson PF, El Kossi MMH, et al. Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int. 2003;63:2050–64.PubMedCrossRef Yang B, Johnson TS, Haylor JL, Wagner B, Watson PF, El Kossi MMH, et al. Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int. 2003;63:2050–64.PubMedCrossRef
11.
Zurück zum Zitat Inoue T, Suzuki H, Okada H. Targeted expression of a pan-caspase inhibitor in tubular epithelium attenuates interstitial inflammation and fibrogenesis in nephritic but not nephrotic mice. Kidney Int. 2012;82:980–9.PubMedCrossRef Inoue T, Suzuki H, Okada H. Targeted expression of a pan-caspase inhibitor in tubular epithelium attenuates interstitial inflammation and fibrogenesis in nephritic but not nephrotic mice. Kidney Int. 2012;82:980–9.PubMedCrossRef
12.
Zurück zum Zitat Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–50.PubMedCentralPubMedCrossRef Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–50.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Inoue T, Takenaka T, Hayashi M, Monkawa T, Yoshino J, Shimoda K, et al. Fibroblast expression of an IkB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol. 2010;21:2047–52.PubMedCentralPubMedCrossRef Inoue T, Takenaka T, Hayashi M, Monkawa T, Yoshino J, Shimoda K, et al. Fibroblast expression of an IkB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol. 2010;21:2047–52.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Okada H, Inoue T, Kikuta T, Watanabe T, Kanno Y, Ban S, et al. A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol. 2006;169:1577–89.PubMedCentralPubMedCrossRef Okada H, Inoue T, Kikuta T, Watanabe T, Kanno Y, Ban S, et al. A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol. 2006;169:1577–89.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Strutz F, Okada H, Lo CW, Danoff TM, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: fSP1. J Cell Biol. 1995;130:393–405.PubMedCrossRef Strutz F, Okada H, Lo CW, Danoff TM, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: fSP1. J Cell Biol. 1995;130:393–405.PubMedCrossRef
16.
Zurück zum Zitat Okada H, Inoue T, Kikuta T, Kato N, Kanno Y, Hirosawa N, et al. Poly(ADP-ribose) polymerase-1 (PARP-1) and PARP-1 binding element enhance murine CCN2 gene transcription in renal tubular epithelial cells. J Am Soc Nephrol. 2008;19:933–42.PubMedCentralPubMedCrossRef Okada H, Inoue T, Kikuta T, Kato N, Kanno Y, Hirosawa N, et al. Poly(ADP-ribose) polymerase-1 (PARP-1) and PARP-1 binding element enhance murine CCN2 gene transcription in renal tubular epithelial cells. J Am Soc Nephrol. 2008;19:933–42.PubMedCentralPubMedCrossRef
17.
18.
Zurück zum Zitat Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, El Nahas AM. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol. 2001;12:485–95.PubMed Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, El Nahas AM. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol. 2001;12:485–95.PubMed
19.
Zurück zum Zitat Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, et al. TNF-a mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol. 2005;288:F406–11.PubMedCrossRef Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, et al. TNF-a mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol. 2005;288:F406–11.PubMedCrossRef
20.
Zurück zum Zitat Meldrum KK, Misseri R, Metcalfe P, Dinarello CA, Hille KL, Meldrum DR. TNF-a neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Integr Comp Physiol. 2007;292:R1456–64.CrossRef Meldrum KK, Misseri R, Metcalfe P, Dinarello CA, Hille KL, Meldrum DR. TNF-a neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Integr Comp Physiol. 2007;292:R1456–64.CrossRef
21.
Zurück zum Zitat Zarjou A, Yang S, Abraham E, Agarwal A, Liu G. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol. 2011;301:F793–801.PubMedCentralPubMedCrossRef Zarjou A, Yang S, Abraham E, Agarwal A, Liu G. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol. 2011;301:F793–801.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM, Winkles JA, Kreztler M, et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol. 2008;19:695–703.PubMedCentralPubMedCrossRef Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM, Winkles JA, Kreztler M, et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol. 2008;19:695–703.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, et al. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med. 2012;18:580–9.PubMedCentralPubMedCrossRef Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, et al. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med. 2012;18:580–9.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Jones LK, O’Sullivan KM, Semple T, Kuligowski MP, Fukami K, Ma FY, et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transpl. 2009;24:3024–32.CrossRef Jones LK, O’Sullivan KM, Semple T, Kuligowski MP, Fukami K, Ma FY, et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transpl. 2009;24:3024–32.CrossRef
25.
Zurück zum Zitat Vilaysane A, Chun J, Seamone ME, Wnag W, Chin R, Hirota S, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21:1732–44.PubMedCentralPubMedCrossRef Vilaysane A, Chun J, Seamone ME, Wnag W, Chin R, Hirota S, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21:1732–44.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Chowdhury P, Sacks SH, Sheerin NS. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephrol Exp Nephrol. 2010;115:e122–30.CrossRef Chowdhury P, Sacks SH, Sheerin NS. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephrol Exp Nephrol. 2010;115:e122–30.CrossRef
27.
Zurück zum Zitat Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, Rink RR, et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res. 2011;168:e61–9.PubMedCentralPubMedCrossRef Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, Rink RR, et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res. 2011;168:e61–9.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Bani-Hani AH, Leslie JA, Asanuma H, Dinarello CA, Campbell MT, Meldrum DR, et al. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int. 2009;76:500–11.PubMedCrossRef Bani-Hani AH, Leslie JA, Asanuma H, Dinarello CA, Campbell MT, Meldrum DR, et al. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int. 2009;76:500–11.PubMedCrossRef
29.
Zurück zum Zitat Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, et al. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1248–57.PubMedCentralPubMedCrossRef Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, et al. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1248–57.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheumatol. 2011;63:3563–74.CrossRef Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheumatol. 2011;63:3563–74.CrossRef
31.
Zurück zum Zitat Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 2010;185:6277–85.PubMedCentralPubMedCrossRef Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 2010;185:6277–85.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, et al. Inflammasome-independent NLRP3 augments TGF-b signaling in kidney epithelium. J Immunol. 2013;190:1239–49.PubMedCrossRef Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, et al. Inflammasome-independent NLRP3 augments TGF-b signaling in kidney epithelium. J Immunol. 2013;190:1239–49.PubMedCrossRef
33.
Zurück zum Zitat Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transpl. 2006;6(2):247–53.CrossRef Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transpl. 2006;6(2):247–53.CrossRef
34.
Zurück zum Zitat Laplante P, Sirois I, Raymond M, Kokta V, Beliveau A, Prat A, et al. Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell Death Differ. 2010;17:291–303.PubMedCrossRef Laplante P, Sirois I, Raymond M, Kokta V, Beliveau A, Prat A, et al. Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell Death Differ. 2010;17:291–303.PubMedCrossRef
35.
Zurück zum Zitat Wang L, Scabilloni JF, Antonini JM, Rojanasakul Y, Castranova V, Mercer RR. Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am J Physiol Lung Cell Mol Physiol. 2006;290(4):L695–702.PubMedCrossRef Wang L, Scabilloni JF, Antonini JM, Rojanasakul Y, Castranova V, Mercer RR. Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am J Physiol Lung Cell Mol Physiol. 2006;290(4):L695–702.PubMedCrossRef
36.
Zurück zum Zitat Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowtiz AN, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010;90:812–23.PubMedCentralPubMedCrossRef Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowtiz AN, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010;90:812–23.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest. 2003;83:655–63.PubMedCrossRef Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest. 2003;83:655–63.PubMedCrossRef
38.
Zurück zum Zitat Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Tsunematsu H, et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest. 2011;121:3343–56.PubMedCentralPubMedCrossRef Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Tsunematsu H, et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest. 2011;121:3343–56.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008;118:1657–68.PubMedCentralPubMedCrossRef Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008;118:1657–68.PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Inoue T, Plieth D, Venkov CD, Xu C, Neilson EG. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 2005;67:2488–93.PubMedCrossRef Inoue T, Plieth D, Venkov CD, Xu C, Neilson EG. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 2005;67:2488–93.PubMedCrossRef
41.
Zurück zum Zitat Oesterreicher CH, Penz-Oesterreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. PNAS. 2011;108:308–13.CrossRef Oesterreicher CH, Penz-Oesterreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. PNAS. 2011;108:308–13.CrossRef
42.
Zurück zum Zitat Iwano M, Fischer A, Okada H, Pleith D, Xue C, Danoff TM, et al. Conditional abatement of tissue fibrosis using nucleotide analogs to corrupt DNA replication selectively in transgenic fibroblasts. Mol Ther. 2001;3:149–59.PubMedCrossRef Iwano M, Fischer A, Okada H, Pleith D, Xue C, Danoff TM, et al. Conditional abatement of tissue fibrosis using nucleotide analogs to corrupt DNA replication selectively in transgenic fibroblasts. Mol Ther. 2001;3:149–59.PubMedCrossRef
43.
Zurück zum Zitat Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transpl. 2013;13:2797–804.CrossRef Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transpl. 2013;13:2797–804.CrossRef
Metadaten
Titel
Effects of cell-type-specific expression of a pan-caspase inhibitor on renal fibrogenesis
verfasst von
Tsutomu Inoue
Takeru Kusano
Kouji Tomori
Hidetomo Nakamoto
Hiromichi Suzuki
Hirokazu Okada
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2015
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1011-0

Weitere Artikel der Ausgabe 3/2015

Clinical and Experimental Nephrology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.